Breaking News Instant updates and real-time market news.

REXN

Rexahn Pharmaceuticals

$2.91 /

+0.06 (+2.11%)

05:12
06/18/20
06/18
05:12
06/18/20
05:12

Rexahn Pharmaceuticals, Ocuphire Pharma announce merger agreement

Rexahn Pharmaceuticals and Ocuphire Pharma announced the companies have entered into a definitive merger agreement under which Ocuphire will merge with a wholly-owned subsidiary of Rexahn in an all-stock transaction. The companies said in a release, "Following closing, which is expected to occur in the second half of 2020, the combined company will change its name to Ocuphire Pharma, Inc. and is expected to trade on the Nasdaq Capital Market under the ticker symbol 'OCUP.' The combined company will focus on the advancement of its pipeline of ophthalmic drug candidates. Certain institutional healthcare and other accredited investors, including certain Ocuphire directors and executives, have also committed to invest $21.15 million in a private placement that will close immediately prior to the closing of the merger, assuming the satisfaction or waiver of customary closing conditions. Investors in this pre-merger financing will receive Ocuphire common stock prior to closing, which will convert into Rexahn common stock upon closing of the merger. Additionally, following the closing of the merger, Rexahn will issue to these investors warrants to purchase shares of Rexahn common stock and, potentially, additional shares of Rexahn common stock. Under the terms of the merger agreement, subject to the satisfaction or waiver of customary closing conditions, including (i) the receipt of the required approval of the Ocuphire stockholders and Rexahn stockholders, (ii) the closing of the pre-merger financing and (iii) Rexahn having a minimum amount of net cash at closing, Ocuphire will merge with a wholly-owned subsidiary of Rexahn, with Ocuphire surviving the merger as a wholly-owned subsidiary of Rexahn. Upon completion of the merger, Ocuphire stockholders will receive newly issued shares of Rexahn common stock pursuant to an exchange ratio formula set forth in the merger agreement. Under the terms of the merger agreement, immediately following the consummation of the merger, Rexahn's then-current stockholders would own approximately 14.3% of the combined company's common stock, and the former Ocuphire securityholders would own approximately 85.7% of the combined company's common stock, in each case calculated on a fully-diluted basis, assuming Rexahn's net cash balance at closing is between $3.2 million and $6.0 million. The exchange ratio formula in the merger agreement is subject to adjustment for every $100,000 that Rexahn's actual net cash balance at closing is less than $3.2 million or more than $6 million. Based on Rexahn's current estimates, Rexahn believes that it is reasonably likely to deliver significantly less than $3.2 million at closing."

REXN Rexahn Pharmaceuticals
$2.91 /

+0.06 (+2.11%)

08/07/19 IFS Securities
Rexahn downgraded to Market Perform from Strong Buy at IFS Securities
08/07/19 H.C. Wainwright
Rexahn Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Technical Analysis
NASDAQ market internals summary » 14:17
07/13/20
07/13
14:17
07/13/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 14:16
07/13/20
07/13
14:16
07/13/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Disney+ orders new animated series 'Star Wars: The Bad Batch' » 14:14
07/13/20
07/13
14:14
07/13/20
14:14
DIS

Disney

$119.76 /

+0.43 (+0.36%)

Disney+ said it ordered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$119.76 /

+0.43 (+0.36%)

DIS Disney
$119.76 /

+0.43 (+0.36%)

10:11 Today
Fly Intel: Top five analyst initiations
05:03 Today Goldman Sachs
Disney initiated with a Buy at Goldman Sachs
07/10/20 JPMorgan
JPMorgan has 'increasing conviction' in Disney returning to health
07/08/20 Guggenheim
Disney price target raised to $123 from $115 at Guggenheim
DIS Disney
$119.76 /

+0.43 (+0.36%)

DIS Disney
$119.76 /

+0.43 (+0.36%)

DIS Disney
$119.76 /

+0.43 (+0.36%)

DIS Disney
$119.76 /

+0.43 (+0.36%)

Recommendations
Lazydays price target raised to $15 from $12 at Craig-Hallum » 14:14
07/13/20
07/13
14:14
07/13/20
14:14
LAZY

Lazydays

$10.55 /

+0.52 (+5.18%)

, CWH

Camping World

$31.37 /

+1.1 (+3.63%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAZY Lazydays
$10.55 /

+0.52 (+5.18%)

CWH Camping World
$31.37 /

+1.1 (+3.63%)

LAZY Lazydays
$10.55 /

+0.52 (+5.18%)

06/30/20 Craig-Hallum
Lazydays continues geographic expansion with 'sizeable' deal, says Craig-Hallum
06/11/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
06/10/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
CWH Camping World
$31.37 /

+1.1 (+3.63%)

06/26/20 Monness Crespi
Camping World price target raised to $28 from $24 at Monness Crespi
06/19/20 JPMorgan
Camping World price target raised to $19 from $11 at JPMorgan
06/02/20 Stephens
Camping World price target raised to $29 from $21 at Stephens
06/01/20 Monness Crespi
Camping World price target raised to $24 from $18 at Monness Crespi
LAZY Lazydays
$10.55 /

+0.52 (+5.18%)

CWH Camping World
$31.37 /

+1.1 (+3.63%)

LAZY Lazydays
$10.55 /

+0.52 (+5.18%)

CWH Camping World
$31.37 /

+1.1 (+3.63%)

CWH Camping World
$31.37 /

+1.1 (+3.63%)

Hot Stocks
Amazon puts new inventory restrictions at warehouses ahead of holiday season » 14:12
07/13/20
07/13
14:12
07/13/20
14:12
AMZN

Amazon.com

$3,268.05 /

+63.99 (+2.00%)

In a post on the Amazon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

08:57 Today Cowen
Amazon.com price target raised to $3700 from $2750 at Cowen
08:53 Today Morgan Stanley
Morgan Stanley says Tesla's 'virtually unchallenged dominance' may be near end
06:40 Today Mizuho
Amazon.com price target raised to $3,450 from $3,100 at Mizuho
06:38 Today Mizuho
Alphabet price target raised to $1,650 from $1,560 at Mizuho
AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

AMZN Amazon.com
$3,268.05 /

+63.99 (+2.00%)

Periodicals
uniQure patent gets IPR review after challenge from Pfizer » 14:07
07/13/20
07/13
14:07
07/13/20
14:07
QURE

uniQure

$47.33 /

+0.91 (+1.96%)

, PFE

Pfizer

$35.56 /

+1.72 (+5.08%)

A trial was instituted at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Guggenheim
uniQure HemB deal 'not the M&A some investors were hoping for,' says Guggenheim
06/25/20 H.C. Wainwright
uniQure price target lowered to $64 from $73 at H.C. Wainwright
06/25/20 Stifel
uniQure price target lowered to $78 from $86 at Stifel
PFE Pfizer
$35.56 /

+1.72 (+5.08%)

09:45 Today Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

  • 06
    Sep
PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

QURE uniQure
$47.33 /

+0.91 (+1.96%)

PFE Pfizer
$35.56 /

+1.72 (+5.08%)

Hot Stocks
easyJet pilots call for vote of no confidence in COO Peter Bellew » 14:06
07/13/20
07/13
14:06
07/13/20
14:06
ESYJY

easyJet

$0.00 /

+ (+0.00%)

Following easyJet's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESYJY easyJet
$0.00 /

+ (+0.00%)

12:20 Today JPMorgan
JPMorgan backs Neutral on easyJet
06/30/20 UBS
easyJet price target lowered to 1,240 GBp from 1,320 GBp at UBS
04/23/20 Morgan Stanley
easyJet downgraded to Equal Weight from Overweight at Morgan Stanley
04/17/20 Oddo BHF
easyJet upgraded to Buy from Neutral at Oddo BHF
Options
Penn National call volume above normal and directionally bullish » 14:05
07/13/20
07/13
14:05
07/13/20
14:05
PENN

Penn National

$30.97 /

+1.52 (+5.16%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

06/23/20 Stifel
Penn National price target raised to $39 from $23 at Stifel
06/09/20 Susquehanna
Penn National downgraded to Neutral from Positive at Susquehanna
06/09/20 Susquehanna
Penn National downgraded to Neutral from Positive at Susquehanna
06/08/20
Fly Intel: Top five analyst downgrades
PENN Penn National
$30.97 /

+1.52 (+5.16%)

  • 12
    May
PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

PENN Penn National
$30.97 /

+1.52 (+5.16%)

General news
Treasury Budget data reported » 14:03
07/13/20
07/13
14:03
07/13/20
14:03

June Treasury Budget at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Wall Street has continued to climb higher » 14:00
07/13/20
07/13
14:00
07/13/20
14:00

Wall Street has continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BioSig announces enrollment of adult patients for ViralClear Phase 2 COVID trial » 13:45
07/13/20
07/13
13:45
07/13/20
13:45
BSGM

BioSig Technologies

$7.36 /

+0.16 (+2.22%)

BioSig Technologies and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Roth Capital
BioSig Technologies initiated with a Buy at Roth Capital
  • 21
    Feb
BSGM BioSig Technologies
$7.36 /

+0.16 (+2.22%)

General news
Fed's Kaplan continues to argue for more fiscal support » 13:45
07/13/20
07/13
13:45
07/13/20
13:45

Fed's Kaplan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Treasury Budget to be reported at 14:00 » 13:45
07/13/20
07/13
13:45
07/13/20
13:45

June Treasury Budget will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
$80M call block in SPYder ETF tied to 2.88M shares » 13:40
07/13/20
07/13
13:40
07/13/20
13:40
SPY

SPDR S&P 500 ETF Trust

$322.27 /

+4.66 (+1.47%)

$80M call block in SPYder…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

SPY SPDR S&P 500 ETF Trust
$322.27 /

+4.66 (+1.47%)

Syndicate
Tonix Pharmaceuticals prices $10.5M common stock offering » 13:38
07/13/20
07/13
13:38
07/13/20
13:38
TNXP

Tonix Pharmaceuticals

$0.55 /

-0.0925 (-14.50%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.55 /

-0.0925 (-14.50%)

Downgrade
Morgan Stanley sees greater uncertainty on NC318, cuts NextCure to Equal Weight » 13:30
07/13/20
07/13
13:30
07/13/20
13:30
NXTC

NextCure

$9.82 /

-7.98 (-44.83%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

NXTC NextCure
$9.82 /

-7.98 (-44.83%)

13:17 Today Morgan Stanley
NextCure downgraded to Equal Weight from Overweight at Morgan Stanley
11:31 Today JMP Securities
NextCure downgraded to Market Perform from Outperform at JMP Securities
09:23 Today SunTrust
NextCure downgraded to Hold from Buy at SunTrust
09:19 Today Roth Capital
NextCure downgraded to Neutral at Roth Capital after Phase II trial update
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

  • 15
    Nov
NXTC NextCure
$9.82 /

-7.98 (-44.83%)

Hot Stocks
Eldorado Resorts gets Indiana HRC approval for Caesars deal » 13:26
07/13/20
07/13
13:26
07/13/20
13:26
ERI

Eldorado Resorts

$41.09 /

+0.93 (+2.32%)

, CZR

Caesars

$12.30 /

+0.085 (+0.70%)

Eldorado Resorts (ERI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/12/20 SunTrust
SunTrust raises price target on select Gaming names amid positive room-rate data
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
CZR Caesars
$12.30 /

+0.085 (+0.70%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura Instinet
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

  • 17
    Jun
ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

ERI Eldorado Resorts
$41.09 /

+0.93 (+2.32%)

CZR Caesars
$12.30 /

+0.085 (+0.70%)

Hot Stocks
Kopin shares up 47c, or 36%, in afternoon trading » 13:25
07/13/20
07/13
13:25
07/13/20
13:25
KOPN

Kopin

$1.81 /

+0.505 (+38.70%)

At time of writing, Kopin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOPN Kopin
$1.81 /

+0.505 (+38.70%)

Options
Pinduoduo call volume above normal and directionally bullish » 13:25
07/13/20
07/13
13:25
07/13/20
13:25
PDD

Pinduoduo

$92.36 /

+5.06 (+5.80%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

06/24/20 Macquarie
Pinduoduo price target raised to $116 from $90 at Macquarie
06/19/20 Morgan Stanley
6.18 promotion in China released pent-up buying demand, says Morgan Stanley
06/16/20 Outperform, Neutral, Underperform
Pinduoduo initiated with an Outperform at ICBC
06/08/20
Fly Intel: Top five analyst initiations
PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

PDD Pinduoduo
$92.36 /

+5.06 (+5.80%)

Conference/Events
Wolfe Research financial analyst to hold an analyst/industry webcast » 13:25
07/13/20
07/13
13:25
07/13/20
13:25

Analysts, along with an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
NextCure downgraded to Equal Weight from Overweight at Morgan Stanley » 13:17
07/13/20
07/13
13:17
07/13/20
13:17
NXTC

NextCure

$9.95 /

-7.855 (-44.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

NXTC NextCure
$9.95 /

-7.855 (-44.13%)

11:31 Today JMP Securities
NextCure downgraded to Market Perform from Outperform at JMP Securities
09:23 Today SunTrust
NextCure downgraded to Hold from Buy at SunTrust
09:19 Today Roth Capital
NextCure downgraded to Neutral at Roth Capital after Phase II trial update
09:05 Today Roth Capital
NextCure downgraded to Neutral from Buy at Roth Capital
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

  • 15
    Nov
NXTC NextCure
$9.95 /

-7.855 (-44.13%)

Technical Analysis
NASDAQ market internals summary » 13:17
07/13/20
07/13
13:17
07/13/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 13:16
07/13/20
07/13
13:16
07/13/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Scotiabank backs Outperform on Tricon Capital » 13:15
07/13/20
07/13
13:15
07/13/20
13:15
TCNGF

Tricon Capital

$0.00 /

+ (+0.00%)

Scotiabank analyst Mario…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCNGF Tricon Capital
$0.00 /

+ (+0.00%)

06/12/20 Scotiabank
Tricon Capital price target raised to C$11 from C$10.25 at Scotiabank
05/26/20 TD Securities
Tricon Capital price target lowered to C$11.50 from C$12 at TD Securities
05/19/20 Stifel
Tricon Capital price target lowered to C$12 from C$14.25 at Stifel
05/19/20 CIBC
Tricon Capital price target lowered to C$12 from C$13.75 at CIBC
Periodicals
Eldorado, Caesars deal approved in Indiana, Casino News reports » 13:15
07/13/20
07/13
13:15
07/13/20
13:15
ERI

Eldorado Resorts

$40.62 /

+0.46 (+1.15%)

, CZR

Caesars

$12.25 /

+0.03 (+0.25%)

The Indiana Horse Racing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/12/20 SunTrust
SunTrust raises price target on select Gaming names amid positive room-rate data
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
CZR Caesars
$12.25 /

+0.03 (+0.25%)

07/08/20 Jefferies
Eldorado Resorts price target raised to $51 from $38 at Jefferies
06/29/20 Stifel
Stifel boosts Eldorado Resorts target to $60, sees 'triple-digit stock' soon
06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura Instinet
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

  • 17
    Jun
ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

ERI Eldorado Resorts
$40.62 /

+0.46 (+1.15%)

CZR Caesars
$12.25 /

+0.03 (+0.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.